Page last updated: 2024-11-02

phenoxybenzamine and Pseudotumor Cerebri

phenoxybenzamine has been researched along with Pseudotumor Cerebri in 1 studies

Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duncan, AW1
Tibballs, J1
Sutherland, SK1

Other Studies

1 other study available for phenoxybenzamine and Pseudotumor Cerebri

ArticleYear
Effects of Sydney funnel-web spider envenomation in monkeys, and their clinical implications.
    The Medical journal of Australia, 1980, Oct-18, Volume: 2, Issue:8

    Topics: Acidosis; Acute Disease; Animals; Arrhythmias, Cardiac; Catecholamines; Cats; Dogs; Fever; Hypertens

1980